Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.560
-0.060 (-3.70%)
At close: Mar 18, 2026, 4:00 PM EDT
1.550
-0.010 (-0.62%)
After-hours: Mar 18, 2026, 7:51 PM EDT

Lexicon Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
661418267375360587
Market Cap Growth
462.50%56.57%-28.76%3.96%-38.56%21.25%
Enterprise Value
626.95371.16129.3304.22276.11501.18
Last Close Price
1.561.150.741.531.913.94
PE Ratio
--8.21-1.17-1.91-3.08-6.57
PS Ratio
13.278.398.59311.242593.281968.90
PB Ratio
5.273.891.834.023.085.17
P/TBV Ratio
5.273.881.623.632.705.05
P/FCF Ratio
--6.16-1.48-2.31-4.00-6.65
P/OCF Ratio
--6.16-1.49-2.31-4.06-6.74
EV/Sales Ratio
12.597.454.16252.671986.421681.81
EV/EBITDA Ratio
--7.69-0.66-1.78-2.75-5.77
EV/EBIT Ratio
--7.59-0.66-1.77-2.74-5.75
EV/FCF Ratio
--5.47-0.72-1.87-3.06-5.68
Debt / Equity Ratio
0.460.460.691.070.460.01
Debt / EBITDA Ratio
-1.12-1.12-0.51-0.58-0.54-0.01
Debt / FCF Ratio
-0.80-0.80-0.56-0.61-0.60-0.01
Net Debt / Equity Ratio
-0.39-0.39-0.94-0.76-0.72-0.75
Net Debt / EBITDA Ratio
0.870.870.700.410.840.99
Net Debt / FCF Ratio
0.620.620.770.430.940.97
Asset Turnover
0.210.210.120.010.000.00
Inventory Turnover
1.071.072.010.45--
Quick Ratio
4.734.735.345.425.973.92
Current Ratio
4.884.885.445.606.084.02
Return on Equity (ROE)
-39.72%-39.72%-167.66%-168.50%-88.37%-65.01%
Return on Assets (ROA)
-20.24%-20.24%-74.69%-81.07%-60.84%-51.12%
Return on Invested Capital (ROIC)
-111.54%-111.54%-915.29%-566.58%-331.38%-392.34%
Return on Capital Employed (ROCE)
-23.44%-23.44%-87.40%-93.09%-70.48%-64.09%
Earnings Yield
-7.62%-12.17%-85.31%-52.29%-32.46%-15.23%
FCF Yield
-10.27%-16.23%-67.35%-43.33%-25.02%-15.04%
Buyback Yield / Dilution
0.12%0.12%0.62%-36.83%-25.89%-5.86%
Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q